The Impact of Cardiovascular Disease on Patients with Type 2 Diabetes
Industry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit
Dr. John Anderson and Dr. Pam Taub discuss the effect of cardiovascular disease on mortality in patients with type 2 diabetes, and the need for a collaborative approach to patient care.
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.